Studies debate role of homocysteine in heart disease
'It's time for the matter to be resolved'
October 27, 1997
Web posted at: 8:30 p.m. EST (0130 GMT)
WASHINGTON (CNN) -- Most people know that smoking, high blood
pressure and diabetes can increase their chances of getting
heart disease.
But whether high levels of homocysteine -- an amino acid
produced when the body breaks down meat and dairy products --
is a risk factor is still not clear. Research reported in two
medical journals this week reach different conclusions.
A glass of milk, a steak or a cheese omelet raise
homocysteine levels at least temporarily, researchers have
found. They also have discovered that people who don't have
enough vitamin B-12 or folic acid in their diet tend to have
high concentrations of homocysteine -- as do some people with
genetic defects.
A study by scientists at the Allegheny University of Health
Sciences in Pittsburgh, reported in the journal
Arteriosclerosis, Thrombosis and Vascular Biology, suggests
that homocysteine may clog heart arteries by making cells
grow in thickness and accumulate collagen.
Collagen is found in the plaque that clogs arteries. The
researchers found that collagen increased after they added
homocysteine to lab dishes of artery cells from a rabbit.
The scientists also found that adding a form of vitamin B-12
to the mixture inhibited the process, lending credence to
studies suggesting that vitamin B-12 or folic acid, another B
vitamin, may lower homocysteine.
'It's time for the matter to be resolved'
Another study by a team of doctors in Hong Kong confirmed the
role of homocysteine in middle-aged adults with hardening of
the arteries. The study, reported in the journal Circulation,
concluded that increased homocysteine was a risk factor.
But another study challenges that premise.
That study, also published in Arteriosclerosis, Thrombosis
and Vascular Biology, found no difference in homocysteine
levels between men who suffered heart attacks and men who had
not.
Dr. David Wilcken of the Prince Henry Hospital in Sydney,
Australia, addresses the contradictory nature of the findings
in an editorial in Circulation.
Noting that it's been 20 years since homocysteine was first
proposed as a possible risk factor for heart disease, he
writes, "Surely the time has come for the matter to be
resolved."